Insulin inhibits AMPK activity and phosphorylates AMPK Ser⁴⁸⁵/⁴⁹¹ through Akt in hepatocytes, myotubes and incubated rat skeletal muscle.

Recent studies have highlighted the importance of an inhibitory phosphorylation site, Ser(485/491), on the α-subunit of AMP-activated protein kinase (AMPK); however, little is known about the regulation of this site in liver and skeletal muscle. We examined whether the inhibitory effects of insulin on AMPK activity may be mediated through the phosphorylation of this inhibitory Ser(485/491) site in hepatocytes, myotubes and incubated skeletal muscle. HepG2 and C2C12 cells were stimulated with or without insulin for 15-min. Similarly, rat extensor digitorum longus (EDL) muscles were treated +/- insulin for 10-min. Insulin significantly increased Ser(485/491) p-AMPK under all conditions, resulting in a subsequent reduction in AMPK activity, ranging from 40% to 70%, despite no change in p-AMPK Thr(172). Akt inhibition both attenuated the increase in Ser(485/491) p-AMPK caused by insulin, and prevented the decrease in AMPK activity. Similarly, the growth factor IGF-1 stimulated Ser(485/491) AMPK phosphorylation, and this too was blunted by inhibition of Akt. Inhibition of the mTOR pathway with rapamycin, however, had no effect on insulin-stimulated Ser(485/491) p-AMPK. These data suggest that insulin and IGF-1 diminish AMPK activity in hepatocytes and muscle, most likely through Akt activation and the inhibitory phosphorylation of Ser(485/491) on its α-subunit.

[1]  David Carling,et al.  AMPK, insulin resistance, and the metabolic syndrome. , 2013, The Journal of clinical investigation.

[2]  B. Kemp,et al.  Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. , 1992, The Journal of biological chemistry.

[3]  I. Shiojima,et al.  Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart* , 2003, Journal of Biological Chemistry.

[4]  M. Prentki,et al.  Coordinate Regulation of Malonyl-CoA Decarboxylase,sn-Glycerol-3-phosphate Acyltransferase, and Acetyl-CoA Carboxylase by AMP-activated Protein Kinase in Rat Tissues in Response to Exercise* , 2002, The Journal of Biological Chemistry.

[5]  N. Fujii,et al.  AMP-activated protein kinase and the regulation of glucose transport. , 2006, American journal of physiology. Endocrinology and metabolism.

[6]  M. Prentki,et al.  AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. , 2005, American journal of physiology. Endocrinology and metabolism.

[7]  N. Turner,et al.  Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase , 2009, Acta physiologica.

[8]  N. Ruderman,et al.  AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity? , 2014, Current Obesity Reports.

[9]  A. Means,et al.  Regulation of AMP-activated Protein Kinase by Multisite Phosphorylation in Response to Agents That Elevate Cellular cAMP*> , 2006, Journal of Biological Chemistry.

[10]  C. Apovian,et al.  Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue[S] , 2012, Journal of Lipid Research.

[11]  G. Cooney,et al.  Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats. , 2006, American journal of physiology. Endocrinology and metabolism.

[12]  R. Somwar,et al.  Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms. , 1998, American journal of physiology. Endocrinology and metabolism.

[13]  B. Kemp,et al.  AMPK in Health and Disease. , 2009, Physiological reviews.

[14]  G. Lopaschuk,et al.  Insulin inhibition of 5' adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. , 1997, Metabolism: clinical and experimental.

[15]  J. Dyck,et al.  Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity. , 2006, American journal of physiology. Heart and circulatory physiology.

[16]  C. Apovian,et al.  Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. , 2011, Biochemical and biophysical research communications.

[17]  A. Gormand,et al.  Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. , 2009, American journal of physiology. Endocrinology and metabolism.

[18]  L. Bertrand,et al.  Insulin antagonizes AMP‐activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides , 2001, FEBS letters.

[19]  F. Ross,et al.  Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells , 2014, The Biochemical journal.

[20]  N. Fujii,et al.  Ablation of AMP-Activated Protein Kinase α2 Activity Exacerbates Insulin Resistance Induced by High-Fat Feeding of Mice , 2008, Diabetes.

[21]  D. Clemmons,et al.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells. , 2011, Endocrinology.

[22]  D. Hardie,et al.  Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. , 2009, American journal of physiology. Endocrinology and metabolism.

[23]  L. Cantley,et al.  p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake. , 2012, Cell metabolism.

[24]  T. Pulinilkunnil,et al.  Adrenergic Regulation of AMP-activated Protein Kinase in Brown Adipose Tissue in Vivo* , 2011, The Journal of Biological Chemistry.

[25]  A. Hebbachi,et al.  Acute regulation of 5′-AMP-activated protein kinase by long-chain fatty acid, glucose and insulin in rat primary adipocytes , 2012, Bioscience reports.

[26]  N. Ruderman,et al.  Nutrient Excess in AMPK Downregulation and Insulin Resistance. , 2013, Journal of endocrinology, diabetes & obesity.

[27]  M. Siegmann,et al.  A stimulated S6 kinase from rat liver: identity with the mitogen activated S6 kinase of 3T3 cells. , 1989, The EMBO journal.

[28]  D. Vertommen,et al.  Insulin Antagonizes Ischemia-induced Thr172 Phosphorylation of AMP-activated Protein Kinase α-Subunits in Heart via Hierarchical Phosphorylation of Ser485/491* , 2006, Journal of Biological Chemistry.

[29]  N. Ruderman,et al.  AMPK activation: a therapeutic target for type 2 diabetes? , 2014, Diabetes, metabolic syndrome and obesity : targets and therapy.

[30]  E. Kraegen,et al.  Downregulation of AMPK Accompanies Leucine- and Glucose-Induced Increases in Protein Synthesis and Insulin Resistance in Rat Skeletal Muscle , 2010, Diabetes.